# TERNS PHARMACEUTICALS INC (TERN)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/TERN/

- Reporting holders: 2
- Reported value: $659.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [MIZUHO SECURITIES USA LLC](https://holderbook.com/funds/812291-mizuho-securities-usa-llc/) | $584.3K | 11,083 | 0.0% | 2 |
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $75.4K | 1,424 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 2 | $659.7K |
| Q1 2026 | 324 | $7.3B |
| Q4 2025 | 248 | $5.0B |
| Q3 2025 | 143 | $676.7M |
| Q2 2025 | 130 | $312.0M |
| Q1 2025 | 139 | $231.0M |
| Q4 2024 | 159 | $481.8M |
| Q3 2024 | 157 | $677.8M |
| Q2 2024 | 126 | $452.3M |
| Q1 2024 | 114 | $426.8M |
| Q4 2023 | 104 | $427.1M |
| Q3 2023 | 96 | $312.6M |